HOME >> BIOLOGY >> NEWS
UW-Madison small-scale research receives big boost

MADISON - The National Science Foundation has awarded the University of Wisconsin-Madison Materials Research Science and Engineering Center (MRSEC) nearly $14.8 million over the next six years to continue its leading-edge research on the interfaces of materials at the nanoscale.

At this scale, materials are so minute that scientists often study or manipulate them atom-by-atom. The work could have wide-ranging applications in electronics and biology, including the use of atomic-scale materials to direct the growth and differentiation of embryonic stem cells.

Initially established in 1996, the interdisciplinary center combines the expertise of more than 30 faculty members in 13 UW-Madison departments and includes nearly 40 graduate students and postdoctoral researchers and about 20 undergraduate students. It was one of 11 re-competing nanotechnology centers to receive recent NSF funding.

"These are extremely, extremely competitive grants," says Juan de Pablo, a professor of chemical and biological engineering and the center's director. "Every major university would like to have a center like this."

With its renewed funding, and with a host of fresh faculty faces on board, the UW-Madison center will embark on several new areas of study, says de Pablo.

One interdisciplinary research group will design liquid-crystalline-based materials that could give scientists spatial and temporal control over the chemical functionality and physical properties of interfaces. "These materials, if successful, could be used to design new sensors for various classes of pathogens, viruses, proteins or toxic chemicals," he says. "And they could be used to influence or guide the growth and differentiation of cells, including human embryonic cells."

Under a secondary aspect of that work, researchers in the group will design substrates, or surfaces, with a controlled chemistry and nanoscale topography. "They will use this ability, again, to contro
'"/>

Contact: Juan de Pablo
depablo@engr.wisc.edu
608-262-7727
University of Wisconsin-Madison
30-Sep-2005


Page: 1 2 3

Related biology news :

1. UW-Madison work on stem cells, cardiac health to be presented at ACS
2. UW-Madison researchers find new way to sweeten key drugs
3. UW-Madison research part of international mercury conference
4. UW-Madison engineers squeeze secrets from proteins
5. $3.4 million directed to key UW-Madison MS study
6. UW-Madison scientists zero in on drugs sweet spots
7. UW-Madison gains two new stem cell programs
8. Water research initiatives at UW-Madison
9. UCI scientists first to predict air quality impact of small-scale power sources
10. NIH gives $8M to University of Pittsburgh School of Medicine for myositis research
11. Saudi Arabias KAUST names WHOI first research partner

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Madison small scale research receives big boost

(Date:5/19/2013)... study reports that white men and women of European ... valgus) and lesser toe deformities, including hammer or claw ... estimate the heritability of foot disorders in humansappear in ... by Wiley on behalf of the American College of ... many as 60% of older adults have foot disorders ...
(Date:5/18/2013)... today at Digestive Disease Week (DDW) explores new discoveries ... of coffee on autoimmune disease and palliative care for ... been associated with reduced risk of fibrosis, a new ... java each month also correlate with lower risk for ... Clinic, Rochester, MN, linked coffee consumption with reduced risk ...
(Date:5/17/2013)... South, but the night belongs to the amphibians. In ... humidity and the sounds of wildlife. , The Southeast, ... salamanders, is the center of amphibian biodiversity in our nation. ... their symphonic choruses, the scientists of the U.S. Geological Survey,s ... , Amphibians, which rely on water for part ...
Breaking Biology News(10 mins):Blame your parents for bunion woes 2Coffee consumption associated with reduced risk of autoimmune liver disease 2Front-row seats to climate change 2Front-row seats to climate change 3Front-row seats to climate change 4
(Date:5/20/2013)... Biomarkers and Clinigene International are set to unveil their ... 2013 AAPS/ National Biotechnology Conference May 20-22 ... Marina , San Diego, CA. ... company representatives at their collaborative seminar, "Biosimilarity, Immunogenicity and ... 1-2 p.m. in the conference,s Spinnaker Room. ...
(Date:5/20/2013)... HILL, N.C. , May 20, 2013 /PRNewswire/ ... company focused on developing differentiated antibiotics to meet ... infections, today announced that it presented data at ... in Philadelphia demonstrating the ... levofloxacin in Cempra,s prior Phase 2 clinical trial ...
(Date:5/20/2013)... Interventional cardiologist Tony Farah, MD, and his ... Cardiovascular Institute have helped pioneer many breakthroughs in ... over the past three decades, from new disease-fighting medications ... artery stent implantation. , Today, AGH officials announced that ... in the study of a novel, first-of-its kind investigational ...
(Date:5/20/2013)... 2013 On 25-28 July, 2013, UPCP ... Paris - the beautiful city of lights. , According ... is revolutionizing the medical world. Understanding and integrating genetic ... hallmark of this transformation. Much of the present medical ... epidemiologic studies of large cohorts that do not take ...
Breaking Biology Technology:Pacific Biomarkers and Clinigene International To Announce Laboratory Solutions for Developers of Biosimilars at 2013 AAPS/ National Biotechnology Conference 2Cempra Presents Post-Phase 2 Analysis of Solithromycin's Efficacy and Safety Results from Patients with Community Acquired Bacterial Pneumonia (CABP) 2Allegheny General Hospital Cardiovascular Institute Becomes Exclusive Pittsburgh Site for Study of Novel Coronary Artery Disease Device 2Allegheny General Hospital Cardiovascular Institute Becomes Exclusive Pittsburgh Site for Study of Novel Coronary Artery Disease Device 3Allegheny General Hospital Cardiovascular Institute Becomes Exclusive Pittsburgh Site for Study of Novel Coronary Artery Disease Device 4The International Congress on Personalized Medicine - Up Close and Personalized 2013 in Paris 2
Cached News: